Science and Technology Science and Technology
Sun, April 6, 2025
Sat, April 5, 2025
Fri, April 4, 2025
Mon, March 31, 2025
Sun, March 30, 2025
Sat, March 29, 2025
Fri, March 28, 2025
Thu, March 27, 2025
[ Thu, Mar 27th ] - SunStar
CIT, Unilab host AIa Summit
Wed, March 26, 2025
Tue, March 25, 2025
Mon, March 24, 2025
Sun, March 23, 2025
Sat, March 22, 2025

Inside the futuristic biotech startup Cellares that's building a cure for cancer with $355 million in funding


//science-technology.news-articles.net/content/2 .. cure-for-cancer-with-355-million-in-funding.html
Published in Science and Technology on Monday, March 24th 2025 at 11:22 GMT by Fortune   Print publication without navigation

  • Scoop ...Haun Ventures, the crypto venture giant that raised $1.5 billion across two funds back near the height of the last blockchain bull market in 2022, is out raising its second round of funds, which are set to total $1 billion. The raise is expected to close in June. I have all the details here.

Cellares, a biotech startup, has raised $255 million in Series C funding, bringing its total funding to $355 million, to revolutionize cancer treatment through automation. The company is developing the Cell Shuttle, an automated manufacturing platform designed to produce cell therapies at scale, aiming to reduce costs and increase accessibility. This platform automates the entire process from cell thawing to final product formulation, potentially allowing for the production of therapies in just a few days compared to weeks or months in traditional methods. Cellares' approach not only promises to make cell therapies more affordable but also aims to standardize the production process, which could lead to more consistent and reliable treatments. The funding will help expand their operations, including building a new manufacturing facility in Bridgewater, New Jersey, and scaling up their technology to meet the growing demand for personalized cancer treatments.

Read the Full Fortune Article at:
[ https://www.msn.com/en-us/money/companies/inside-the-futuristic-biotech-startup-cellares-that-s-building-a-cure-for-cancer-with-355-million-in-funding/ar-AA1BxAz9 ]

Publication Contributing Sources